Heritage Provider Network logo

Heritage Provider Network

North America, California, United States, Northridge

Description

Heritage Provider Network (HPN) is a limited Knox-Keene licensed organization.

Investor Profile

Heritage Provider Network has made 13 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (31%)
  • Series A (31%)
  • Seed (23%)
  • Series B (15%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Genetics
  • Life Science
  • Health Diagnostics
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Emergency Medicine
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Heritage Provider Network frequently co-invest with?

Mitsui & Co
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 3
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 2
Third Rock Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
Casdin Capital
North America, New York, United States, New York
Co-Investments: 2
Digitalis Ventures
North America, New York, United States, New York
Co-Investments: 2
OS Fund
North America, Illinois, United States, Chicago
Co-Investments: 2
Innovation Endeavors
North America, California, United States, Palo Alto
Co-Investments: 2
Cambia Health Solutions
North America, Oregon, United States, Portland
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2

Which angels does Heritage Provider Network often collaborate with?

JG
North America, California, United States, Culver City
Shared Deals: 1

What are some of recent deals done by Heritage Provider Network?

Celsius Therapeutics

Cambridge, Massachusetts, United States

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

BiotechnologyEmergency MedicineGeneticsHealth CarePrecision Medicine
Series BMar 24, 2022
Amount Raised: $83,000,000
InterVenn

South San Francisco, California, United States

InterVenn unlocks the glycoproteome using artificial intelligence for the development of transformational healthcare solutions in DX and Rx.

Artificial Intelligence (AI)BiotechnologyHealth CareLife ScienceMedical
Series CAug 2, 2021
Amount Raised: $201,000,000
Circumvent

Portland, Oregon, United States

Circumvent is a biotech company

BiotechnologyHealth CarePharmaceutical
SeedDec 9, 2020
Amount Raised: $4,092,000
RubiconMD

New York, New York, United States

RubiconMD empowers and innovates for primary care by democratizing medical expertise.

ConsultingHealth CareInformation ServicesInformation TechnologyMedicalmHealthPrimary and Urgent Care
Series CMar 10, 2020
Amount Raised: $18,000,000
GRO Biosciences

Boston, Massachusetts, United States

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

BiotechnologyHealth DiagnosticsMedicalPharmaceuticalTherapeutics
SeedMar 13, 2019
Amount Raised: $3,500,000
Glympse Bio

Cambridge, Massachusetts, United States

Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.

BiotechnologyHealth CareLife ScienceMedical DeviceNanotechnology
Series AOct 9, 2018
Amount Raised: $22,000,000
Digital Diagnostics

Coralville, Iowa, United States

Digital Diagnostics is an AI diagnostics company that transforms the quality, accessibility, and affordability of healthcare.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMachine LearningMedical Device
Series ASep 27, 2018
Amount Raised: $32,599,976
Celsius Therapeutics

Cambridge, Massachusetts, United States

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

BiotechnologyEmergency MedicineGeneticsHealth CarePrecision Medicine
Series AMay 15, 2018
Amount Raised: $65,000,000
GRO Biosciences

Boston, Massachusetts, United States

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

BiotechnologyHealth DiagnosticsMedicalPharmaceuticalTherapeutics
SeedFeb 8, 2018
Amount Raised: $2,400,000
Scientist.com

Solana Beach, California, United States

Scientist.com is a network of public and private e-commerce marketplaces that connect buyers and sellers of scientific research services.

BiotechnologyMarketplaceOutsourcing
Series CMay 15, 2017
Amount Raised: $24,000,000